China NMPA Product Recall - Infusion System

AngioDynamics, Inc. has initiated a voluntary Class II recall for certain infusion systems due to a critical manufacturing defect. This action was reported by Shanghai Meichuang Medical Device Co., Ltd. and publicly announced by the National Medical Products Administration (NMPA) on June 27, 2024. The core issue involves a faulty rotating adapter O-ring within the infusion systems, which poses a significant risk of drug leakage during patient infusion. This defect could compromise the integrity of the medical procedure and potentially affect patient safety. Operating under the NMPA's regulatory framework for medical device oversight, AngioDynamics, Inc. is taking proactive steps to address this quality concern. The specific infusion systems impacted are those registered under National Medical Device Registration Certificate No. 20183031982; detailed model and batch information is available in the official "Medical Device Recall List." The required action involves the systematic voluntary recall of all affected units to prevent potential adverse events. Crucially, the NMPA has confirmed that the specific products involved in this recall were not imported into China, mitigating direct impact on the Chinese healthcare market. This recall underscores the continuous need for stringent quality control in medical device manufacturing and regulatory vigilance.